ABASAGLAR, created in 2014 (United States), from 588 sister brands and 17477 competing brands. ABASAGLAR is owned by ELI LILLY AND COMPANY, listed on the stock exchange of New York ABASAGLAR belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
ELI LILLY AND COMPANY
(ABASAGLAR)
over 5 years*
USD 4,756.45